Loading ...

Pilot Study to Determine the Immunogenecity of Immucothel and Oral Tolerance Induction with Biosyn N

(

TAKE

)

ITN Protocol #:

ITN047AI

Branded Name:

TAKE

ClinicalTrials.Gov ID:

NCT01489956

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Completed

Summary:

Pilot Study to Determine the Immunogenicity of Immucothel® and Oral Tolerance Induction with Biosyn Native KLH in Healthy Subjects

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

Rho Data Manager

Study Personnel:

Protocol Chair

Patti Tostaptosta@immunetolerance.org

Work: 

415-353-4421

Protocol Chair

Kristina Harris, PhD

Work: 

Protocol Chair

Dawn Smilek, MD PhDdsmilek@immunetolerance.org

Work: 

415-353-4308

Protocol Chair

Susan Boohersusan.booher@nih.gov

Work: 

240-627-3481

Protocol Chair

LaSonia MorganLaSonia_Morgan@rhoworld.com

Work: 

919-595-6379